The effect of the COVID-19 pandemic on alcohol use and psycho-somatic health in pregnant and postpartum women with intersecting vulnerabilities.

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R01AA021771-08S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2013
    2023
  • Known Financial Commitments (USD)

    $134,896
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Ludmila Nicole Bakhireva
  • Research Location

    United States of America
  • Lead Research Institution

    University Of New Mexico Health Scis Ctr
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

SUMMARY/Abstract: The new clinical guidelines for diagnosing Fetal Alcohol Spectrum Disorders (FASD) list self-regulation as oneof the key behavioral deficits in children affected by prenatal alcohol exposure (PAE). There is a fundamentalgap in knowledge about the underlying mechanisms, spectrum, and severity of such deficits early in life and thebest analytical approaches to identify them. In addition, the effect of prenatal stress and postnatal environmenton PAE-induced alterations is poorly understood. The primary focus of the parent Ethanol, Neurodevelopment,Infant, and Child Health 2 (ENRICH-2) study is on identification of neurobehavioral deficits associated with PAEearly in life. This administrative supplement will allow us to examine the comorbid effect of COVID-19 pandemicand alcohol use on adverse maternal and infant outcomes in this cohort. The long-term goal of this supplementis to characterize the psycho-social effect of COVID-19 pandemic on adverse outcomes, including alcohol use,in a longitudinal birth cohort study, thus providing the foundation for future intervention studies. The objective ofthis supplement is to comprehensively evaluate the effect of COVID-19 related stress in pregnant andpostpartum women enrolled in the ENRICH-2 cohort. We will evaluate this by adding state-of-the-art self-reported measures integrated with real-time physiological data that are not currently part of the funded parentstudy. The rationale for this supplement is driven by the gap in knowledge about the effect of the COVID-19pandemic on psychosocial outcomes, alcohol use, and stress-related physical outcomes in pregnant andpostpartum women, a vulnerable population disproportionately affected. We will address this gap in knowledgeby pursuing two specific aims which evaluate the effect of COVID-19 on adverse maternal and infant outcomesin the ENRICH-2 cohort: 1) psychosocial outcomes and alcohol use, assessed as COVID-19 stress related toexposures and symptoms, COVID-19 pandemic adjustment, emotion regulation, mother-infant attachment, andalcohol consumption and 2) physiologic outcomes assessed as heart rate variability and sleep patterns,evaluated by wearable electronics - an approach particularly novel in the current social distancing environment.This approach is highly innovative, and will allow for the objective, real-time data collection in the climate ofprolonged social distancing and challenges associated with face-to-face research visits in vulnerablepopulations. A detailed characterization of COVID-19 related outcomes in pregnant and postpartum women,effect of COVID-related social isolation and other hardships on mental health and alcohol use, as well as thecumulative effect on pediatric neurodevelopmental outcomes are highly significant in order to lay out thefoundation for early effective interventions to mitigate the effects in these vulnerable populations.